A copy of this work was available on the public web and has been preserved in the Wayback Machine. The capture dates from 2017; you can also visit the original URL.
The file type is application/pdf
.
Metformin improve upper tract urothelial carcinoma survival in Taiwanese patients with type 2 diabetes
2016
Urological Science
Purpose: The oral diabetes medicine metformin might have chemopreventive effects against cancer which was discussed before. However, no clinical study exists for analyzing the effect of metformin in upper tract urothelial carcinoma survival condition in type 2 diabetes patients which presents an unusual feature in Taiwan. Therefore, we want to realize if metformin can improve survival rate in upper tract urothelial carcinoma patients through a population-based analysis. Materials and Methods:
doi:10.1016/j.urols.2016.05.015
fatcat:4xjsqqbibrczdifvxvgqtc7vrm